Israel - English - Ministry of Health

teva israel ltd - entecavir as monohydrate - film coated tablets - entecavir as monohydrate 1 mg - entecavir - entecavir teva is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: - compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (alt) levels. - decompensated liver disease.

Israel - English - Ministry of Health

neopharm ltd, israel - obeticholic acid - film coated tablets - obeticholic acid 10 mg - obeticholic acid - ocaliva is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca or as monotherapy in adults unable to tolerate udca.

Israel - English - Ministry of Health

neopharm ltd, israel - obeticholic acid - film coated tablets - obeticholic acid 5 mg - obeticholic acid - ocaliva is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca or as monotherapy in adults unable to tolerate udca.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - esmolol hydrochloride (unii: v05260lc8d) (esmolol - unii:mdy902uxsr) - esmolol hydrochloride in sodium chloride injection is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol hydrochloride in sodium chloride injection is also indicated in non-compensatory sinus tachycardia where, in the physician’s judgment, the rapid heart rate requires specific intervention. esmolol hydrochloride in sodium chloride injection is intended for short-term use. esmolol hydrochloride in sodium chloride injection is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the post-operative period, when in the physician’s judgment such specific intervention is considered indicated. use of esmolol hydrochloride in sodium chloride injection to prevent such events is not reco

United States - English - NLM (National Library of Medicine)

intercept pharmaceuticals inc - obeticholic acid (unii: 0462z4s4oz) (obeticholic acid - unii:0462z4s4oz) - obeticholic acid 5 mg - ocaliva® is indicated for the treatment of adult patients with primary biliary cholangitis (pbc) - without cirrhosis or - with compensated cirrhosis who do not have evidence of portal hypertension, either in combination with ursodeoxycholic acid (udca) with an inadequate response to udca or as monotherapy in patients unable to tolerate udca. this indication is approved under accelerated approval based on a reduction in alkaline phosphatase (alp) [see clinical studies (14)] . an improvement in survival or disease-related symptoms has not been established. continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. ocaliva is contraindicated in patients with: - decompensated cirrhosis (e.g., child-pugh class b or c) or a prior decompensation event [see warnings and precautions (5.1)] . - compensated cirrhosis who have evidence of portal hypertension (e.g., ascites, gastroesophageal varices, persistent thrombocytopenia) [see warnings and

Singapore - English - HSA (Health Sciences Authority)

hyphens pharma pte. ltd. - clarithromycin - capsule, delayed release - 200mg - clarithromycin 200mg

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - sufentanil - solution for injection/infusion - sufentanil 5 µg/ml - anesthetics

Malta - English - Medicines Authority

medochemie limited 1-10 constantinoupleos street, 3011 limassol, cyprus - sufentanil - solution for injection/infusion - sufentanil 50 µg/ml - anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - esmolol hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; glacial acetic acid; sodium hydroxide; sodium acetate trihydrate - esmolol hydrochloride medicianz is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol hydrochloride medicianz is also indicated in non-compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. esmolol hydrochloride medicianz is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - adefovir dipivoxil - tablet - 10 mg - adefovir dipivoxil 10 mg